Highlights:
Brain-Computer Interfaces and Remote Surgery Included: Three Chinese Authorities Release 2026 High-End Medical Equipment Promotion Program, Covering 17 Categories
China has launched its 2026 high-end medical equipment promotion program, covering 16 priority products and one typical application scenario. Implantable brain-computer interfaces and remote laparoscopic surgery are among the newly highlighted areas, while participating products are required to have obtained Chinese medical device registration certificates.
September 14, 2026
Fresh Update: NHSA Holds Surgical Robotics Symposium, Signaling Several Clear Policy Directions
China’s National Healthcare Security Administration has held a symposium with seven surgical robotics companies and five hospitals, highlighting several emerging policy directions for the sector, including pricing, DRG/DIP payment, real-world value assessment, data standards and remote surgery.
September 12, 2026
148 Companies Proposed for Selection: China’s Seventh National High-Value Consumables Procurement Covers 23 GI Interventional Product Categories
China’s seventh national high-value medical consumables procurement round has produced proposed winning results, with 148 companies and 517 products selected across 23 gastrointestinal interventional product categories. The latest round also introduces revised pricing rules designed to curb excessive low-price competition.
September 11, 2026
How Chinese Public Hospitals Buy Medical Devices in 2026: Procurement, Tendering and Market Access Explained
NMPA approval allows a medical device onto the Chinese market, but it does not guarantee a hospital purchase. This guide explains how clinical demand, internal review, budgeting, tendering and centralized procurement shape access to China’s public hospitals—and where MedTech companies need to engage before a tender begins.
August 19, 2026
